25,924 results on '"Endometrial neoplasms"'
Search Results
2. ALPINE: Maintenance Letrozole/Abemaciclib Vs Pembrolizumab
3. Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
4. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
5. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
6. A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
7. A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018
8. A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
9. Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
10. First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients with Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers
11. A Pilot and Mixed-Methods Study of GYNecologic Cancer-Related COGnitive Impairment (GYNCOG)
12. VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
13. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
14. GEN1047 for Solid Tumors - First in Human (FIH) Trial
15. Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
16. GEN1046 Safety Trial in Patients With Malignant Solid Tumors
17. A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
18. Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer (SLN-EC-01)
19. A Study of PARG Inhibitor IDE161 in Participants with Advanced Solid Tumors
20. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
21. A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
22. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
23. Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
24. Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer (ECHO)
25. IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
26. A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
27. A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer (EndomERA)
28. A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
29. First in Human Study of TORL-1-23 in Participants With Advanced Cancer
30. Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer
31. ZW25 in Women With Endometrial Cancers
32. Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
33. Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)
34. A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
35. Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
36. Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. (EDO-S101)
37. Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
38. Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) (TroFuse-005)
39. Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (PETRA)
40. BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer
41. Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
42. A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients
43. MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
44. Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study (PENDOR)
45. Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer
46. Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer
47. Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence (SISTER)
48. Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
49. A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
50. Tempus Priority Study: a Pan-tumor Observational Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.